Mark E Saad Axsome Therapeutics, Inc. (AXSM) insider trading activity

Mark E Saad is of Axsome Therapeutics, Inc.. Currently has a direct ownership of 10,002 shares of AXSM, which is worth approximately $1.4 Million. The most recent transaction as insider was on Dec 31, 2025, when has been sold 37,577 shares (Common Stock) at a price of $165.18 per share, resulting in proceeds of $6,206,968. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10K

0% 3M change

0% 12M change

Total Value Held $1.4 Million

Mark E Saad Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 31 2025	SELL Open market or private sale	$6,206,968 $165.18 p/Share	37,577 Reduced 78.98%	10,002 Common Stock
Dec 31 2025	BUY Exercise of conversion of derivative security	$243,874 $6.49 p/Share	37,577 Added 47.61%	41,348 Common Stock
Sep 05 2025	SELL Open market or private sale	$1,141,513 $125.07 p/Share	9,127 Reduced 47.71%	10,002 Common Stock
Sep 05 2025	BUY Exercise of conversion of derivative security	$82,143 $9.0 p/Share	9,127 Added 32.3%	19,129 Common Stock
Sep 11 2024	SELL Open market or private sale	$1,005,870 $91.31 p/Share	11,016 Reduced 52.41%	10,002 Common Stock
Sep 11 2024	BUY Exercise of conversion of derivative security	$40,428 $3.67 p/Share	11,016 Added 34.39%	21,018 Common Stock
Nov 17 2021	BUY Open market or private purchase	$103,590 $34.53 p/Share	3,000 Added 23.07%	10,002 Common Stock

Also insider at

RMED

Ra Medical Systems, Inc. Healthcare

Director

MES

Mark E Saad

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AXSM shares.

Notify only if

Value

Insider Trading

Get notified when an Axsome Therapeutics, Inc. insider buys or sells AXSM shares.

Notify only if

Operation

Value

Type

News

Receive news related to Axsome Therapeutics, Inc.

Track Activities on AXSM

Account